chronic kidney disease

Keryx's kidney drug meets main goals of mid-stage study
Yahoo/Reuters
Tue, 11/5/13 - 09:56 am
Keryx
Zerenex
chronic kidney disease
3 Things You Need to Know from Keryx's Stifel Conference Presentation
Motley Fool
Sat, 09/14/13 - 11:02 am
Keryx
chronic kidney disease
dialysis
hyperphosphatemia
Zerenex
Keryx's First Step Toward Zerenex Approval
Motley Fool
Sat, 08/10/13 - 12:40 pm
Keryx
Zerenex
chronic kidney disease
Rockwell Medical: Undervalued After CRUISE-1 Results
Seeking Alpha
Fri, 07/12/13 - 08:21 am
Rockwell Medical
chronic kidney disease
Soluble Ferric Pyrophosphate
Takeda Withdraws MAA for Omontys in Europe
NASDAQ
Sat, 07/6/13 - 12:30 pm
Takeda
Omontys
chronic kidney disease
Keryx Patents Seen Overcoming Generic Competition
Investors.com
Wed, 06/19/13 - 03:55 pm
Keryx
patents
generics
chronic kidney disease
Zerenex
Multiple Pending Catalysts Should Keep Investor Interest Strong For Rockwell Medical
Seeking Alpha
Wed, 06/12/13 - 08:49 am
Rockwell Medical
chronic kidney disease
AMAG Pharmaceuticals Announces a Positive CHMP Opinion for the Approval of Ferumoxytol in Europe for the Treatment of Iron Deficiency Anemia in Adult Patients with Chronic Kidney Disease
Enhanced Online News
Sat, 04/21/12 - 01:24 pm
Ferumoxytol
Amag Pharmaceuticals
anemia
chronic kidney disease
Affymax Poised To Take On Amgen?
Seeking Alpha
Fri, 04/6/12 - 11:15 am
Amgen
Affymax
Regeneron
Alnylam
Omontys
chronic kidney disease
Dynavax reports final Phase 3 data for HEPLISAV
Yahoo/Fly on the Wall
Tue, 03/27/12 - 10:05 am
Heplisav
Dynavax
chronic kidney disease
US FDA panel gives positive opinion to Affymax's anaemia drug peginesatide
Pharmabiz
Sat, 12/10/11 - 01:23 pm
Affymax
peginesatide
Takeda
chronic kidney disease
Affymax Jumps Most in 16 Months on FDA Review of Anemia Drug
Bloomberg
Mon, 12/5/11 - 01:34 pm
Affymax
FDA
anemia
chronic kidney disease
JNJ
Amgen
peginesatide
Affymax and Takeda Report Additional Analyses of Peginesatide Phase 3 Studies in Dialysis Patients at the American Society of Nephrology’s Kidney Week 2011
Yahoo/BusinessWire
Sat, 11/12/11 - 12:16 pm
peginesatide
chronic kidney disease
dialysis
Affymax
Takeda
FDA sets date to review Affymax anemia drug
Yahoo/AP
Mon, 10/24/11 - 11:36 am
FDA
Affymax
anemia
peginesatide
chronic kidney disease
Abbott Reveals Positive Results From Phase-2 Trial Of Kidney Drug
RTT News
Sat, 06/25/11 - 11:03 am
Abbott Laboratories
bardoxolone methyl
chronic kidney disease
FDA recommends lower doses of anemia drugs
Yahoo/AP
Sat, 06/25/11 - 10:37 am
Aranesp
Procrit
Epogen
chronic kidney disease
Amgen Announces Modifications to U.S. Prescribing Information for Use of Erythropoiesis-Stimulating Agents in Chronic Kidney Disease
Yahoo/PR NewsWire
Sat, 06/25/11 - 10:35 am
Amgen
Aranesp
Epogen
chronic kidney disease
Abbott's Bardoxolone in Phase III
Yahoo/Zacks
Sat, 06/18/11 - 10:25 am
diabetes
chronic kidney disease
Bardoxolone
Abbott Laboratories
Affymax, Takeda seek approval of peginesatide in dialysis patients with chronic kidney disease
Yahoo/AP
Tue, 05/31/11 - 12:39 pm
chronic kidney disease
Takeda
Hematide/peginesatide
Affymax
Proteon Therapeutics advances drug candidate, sale to Novartis
Bizjournals.com
Thu, 04/14/11 - 06:18 pm
PRT-201
Proteon
Novartis
chronic kidney disease

Pages